VA awards industry innovators with health IT projects

Secretary of Veterans Affairs Eric K. Shinseki has announced the first VA Innovation Initiative (VAi2) awards under the agency’s Industry Innovation Competition. These four projects will use new technologies in VA facilities to improve the quality of patient care for veterans and are the first of nearly 24 more awards to be made in the coming months, according to the agency.

  • mVisum, of Camden, N.J., received an award to fund a pilot project at the Washington D.C. VA Medical Center that enables healthcare providers to wirelessly review, share and respond to cardiology data on mobile devices.
  • Agilex Technologies, based in Chantilly, Va., received funds for an alternative pilot project at the same Washington D.C. VA Medical Center. This pilot will explore the ability to extend elements of VA’s EMR to electronic devices. The pilot will allow patient search, demographics, laboratory data, medications, allergies, appointments and problem lists to be displayed. Agilex will also integrate clinic schedules and secure messaging onto the device.
  • MedRed, based in Washington, D.C., was awarded funds for a project at the McGuire VA Medical Center’s Polytrauma Clinic in Richmond, Va., to field test software that helps providers more easily share new and innovative treatment strategies to improve care for veterans being treated for traumatic brain injury.
  • The fourth award, made to Venture Gain, of Naperville, Ill., funds a project at the George E. Wahlen VA Medical Center in Salt Lake City. The project will pilot a next-generation system of wearable sensors combined with software analytics to predict and prevent complications for patients diagnosed with heart failure.

VAi2 identifies, funds and evaluates new ideas from VA employees, academia and the private sector. The Industry Innovation Competition was the third competition launched by VAi2 and is the first to involve the private sector. Additional awards will be announced as contracting for selected innovations is completed, according to the VA.

 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.